Sunshine Biopharma Inc. (SBFM): Price and Financial Metrics

Sunshine Biopharma Inc. (SBFM): $1.77

1.55 (-46.69%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

SBFM Price/Volume Stats

Current price $1.77 52-week high $140.00
Prev. close $3.32 52-week low $1.73
Day low $1.73 Volume 11,903,200
Day high $2.45 Avg. volume 453,490
50-day MA $7.34 Dividend yield N/A
200-day MA $27.60 Market Cap 1.76M

SBFM Stock Price Chart Interactive Chart >


Sunshine Biopharma Inc. (SBFM) Company Bio


Sunshine Biopharma, Inc. engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. Its products include treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Pointe-Claire, Canada.


SBFM Latest News Stream


Event/Time News Detail
Loading, please wait...

SBFM Latest Social Stream


Loading social stream, please wait...

View Full SBFM Social Stream

Latest SBFM News From Around the Web

Below are the latest news stories about SUNSHINE BIOPHARMA INC that investors may wish to consider to help them evaluate SBFM as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!

William White on InvestorPlace | December 5, 2023

Sunshine Biopharma Moves Principal Office to New York City

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM”) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has moved its headquarters to New York City. The Company’s Head Office is now located at 1177 Avenue of the Americas, 5th Floor, New York, NY 10036 (Tel: 332-216-1147). The Company will maintain a satellite office at its previous hea

Yahoo | December 4, 2023

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

MONTREAL, QC / ACCESSWIRE / November 13, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today ...

Yahoo | November 13, 2023

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has received a 180-day extension, until March 18, 2024, to achieve compliance with the Nasdaq $1.00 minimum bid price rule.

Yahoo | September 22, 2023

It's Down 26% But Sunshine Biopharma, Inc. (NASDAQ:SBFM) Could Be Riskier Than It Looks

To the annoyance of some shareholders, Sunshine Biopharma, Inc. ( NASDAQ:SBFM ) shares are down a considerable 26% in...

Yahoo | September 12, 2023

Read More 'SBFM' Stories Here

SBFM Price Returns

1-mo -70.00%
3-mo -92.28%
6-mo -94.55%
1-year -97.36%
3-year -99.93%
5-year -99.96%
YTD -93.48%
2023 -57.58%
2022 -94.53%
2021 272.61%
2020 57.00%
2019 -96.88%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!